Medical Devices

Request for TOC Request for Sample
BUY NOW

Europe Bioinformatics Market – Industry Trends and Forecast to 2029

Medical Devices | Published Report | Aug 2022 | Europe | 350 Pages | No of Tables: 295 | No of Figures: 48

COVID-19 Impact on mHealth in the Healthcare Industry

Report Description

Europe Bioinformatics Market, By Type (Knowledge Management Tools, Bioinformatics Software and Services), Sector (Medical Biotechnology, Academics, Animal Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Others), Application (Genomics & Drug Development, Proteomics, Evolutionary Studies, Agricultural Studies, Veterinary Science, Metabolomics, Transcriptomics and Others), Purchase Mode (Group Purchase and Individual Purchase), Method (Genomics and Proteomics) End-User, (Research and Academic Institutes, Clinical Research Organization, Biotech and Pharmaceutical Companies, Research Laboratories, Hospital and Others) - Industry Trends and Forecast to 2029.

Get Exclusive Sample Copy of this Report Here

Europe Bioinformatics Market Analysis and Insights

The drivers responsible for the growth of the  bioinformatics market are the less cost of genetic sequencing per base, growing need for bioinformatics, wide product portfolio offered by major market players and use of bioinformatics in personalized medicine and increased public-private sector funding for bioinformatics. However, factors expected to restrain the market growth are the rise in the cost of instrumentation, difficulty in clinical bioinformatics analysis and cyber security in bioinformatics.

Get Exclusive Sample Copy of this Report Here

Get Exclusive Sample Copy of this Report Here

On the other hand, strategic initiatives by market players, product development, advancements in bioinformatics technology and a rise in healthcare expenditure may act as an opportunity for the growth of the  bioinformatics market. However, the need for skilled expertise, challenges in implementing bioinformatics technology in clinical laboratories and regulatory approval may create challenges for the  bioinformatics market. There are recent developments related to the worldwide  bioinformatics market.

The rise in research and development activities in bioinformatics in Europe is expected to boost the market growth. Data Bridge Market Research analyzes that the Europe Bioinformatics market will grow at a CAGR of 19.5% during the forecast period of 2022 to 2029.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Type (Knowledge Management Tools, Bioinformatics Software and Services), Sector (Medical Biotechnology, Academics, Animal Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Others), Application (Genomics & Drug Development, Proteomics, Evolutionary Studies, Agricultural Studies, Veterinary Science, Metabolomics, Transcriptomics and Others), Purchase Mode (Group Purchase and Individual Purchase), Method (Genomics and Proteomics) End-User, (Research and Academic Institutes, Clinical Research Organization, Biotech and Pharmaceutical Companies, Research Laboratories, Hospital and Others)

Countries Covered

Germany, France, U.K., Italy,  Russia, Spain, Switzerland, Netherlands, Belgium, Turkey, Rest of Europe

Market Players Covered

Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Waters Corporation, Dassault Systèmes, Bayer AG, PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam and GenoFAB, Inc.

Market Definition

Bioinformatics combines computer programming, big data, and Molecular Biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.

From genetics to toxicology to mycology and radiobiology, there are scores of branches of Biology to specialize in. And out of the many, Bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of Computer Science, Statistics, and Biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, etc.

  • In the coming future, important decisions related to bioinformatics on drug discovery will be made by individuals who not only understand the biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify quality targets

Europe Bioinformatics Market Dynamics

Drivers

  • Wide Product Portfolio Offered by Major Players

The advancement and growing research in the field of bioinformatics offered by major players allows them to develop and launch new products in the market. The different sequencing instruments are in the  bioinformatics market.

For instance,

  • The product portfolio of QIAGEN consists of bioinformatics products and services such as custom automated workflows, curation services, and scalable bioinformatics services
  • BGI consists of sequencing services and mass spectrometry services such as proteomics, metabolomics, multi-omics, and biologics characterization
  • The gene synthesis and molecular biology by Eurofins Scientific provides gene synthesis and Molecular Biology products

Hence, the product portfolio for the companies working in this market is vast, due to which the companies' revenue has increased continuously from the past recent revenue year. This is expected to propel the market size and is expected to act as a driver for the  bioinformatics market in the forecast period

  • Growing Need for Bioinformatics

As genomics-focused pharmacology continues to play a greater role in the treatment of various chronic diseases, especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight into the molecular underpinnings of individual tumors and specific receptors. Informatics is essential in biological research involving biologists who learn programming, computer programmers, mathematicians, or database managers who learn the foundations of biology

For instance,

  • NGS has also been explored for comprehensive profiling of pharmacogenetics with relevance to drug Pharmacokinetics and Pharmacodynamics. An initial report in 2017 suggested that this technology may represent a reliable and efficient tool for discovering both common and rare genetic variations in these genes

  • Bioinformatics is the application of tools of computation and analysis to the capture and interpretation of biological data

Bioinformatics has the power to transform oncology's outlook and push forward the vision of precision medicine by adopting genome-focused pharmacology to treat chronic diseases. Thus, the increase in the adoption of genome-focused pharmacology for chronic disease treatment acts as a driver for the  bioinformatics market.

Opportunities

  • Use Of Bioinformatics In Personalized Medicine

The growth curve for  bioinformatics market clinical applications is following an upward trend as established applications are gaining momentum and new ones are finding a foothold. Product development in the past years has helped the market size to grow. This also shows the support of the regulatory agency for allowing these products in the market.

  • Strategic Initiatives by Market Players

Bioinformatics delivers purposeful biological information, as it is a part of life science dealing with the comprehension and planning of genomes. A genome is the complex arrangement of genetic sets present in a cell or a whole living being. Personalized medicine is a combinatorial way to deal with individual-specific health care. The patient-specific medication development advanced through bioinformatics tools.

For instance-

  • In December 2020, Quest Diagnostics Incorporated invested in Structural Bioinformatics, A Leader in Computational Proteomics and Structural Pharmacogenomics. The investment resulted in the joint development of a series of database modules of the novel, structurally variant proteins and market these products directly to the pharmaceutical and biotechnology industry for use in the development of personalized medicine
  • In 2019, BGI announced that Flow Pharma had selected BGI (A subsidiary of BGI Group) for developing the use of NSG in Drug Development

Hence the growing prevalence of chronic disease and increased drug-resistance issues in traditional medication have generated the demand for increasing bioinformatics in drug development. This is expected to be one of the major factors expected to drive the market growth in the forecast period.

Restraints/Challenges

  • Difficulty In Clinical Bioinformatics Analysis

The largely untapped potential of big data analytics is a feed buzz that has been exacerbated by the production of many next-generation data sets that seek to answer long-standing questions about the biology of human diseases. Although these approaches are likely to be a powerful means of unveiling new biological insights, several significant challenges currently hinder efforts to harness the power of big data. Typical challenges include the effective assessment of analytical software tools, the speeding up of the overall process using hybrid parallel computing (HPC) parallelization and acceleration technology, the advancement of automation strategies, data storage alternatives, and, finally, the development of new methods for the full utilization of results across multiple experimental conditions.

Considering the uncertainty about the importance of certain bioinformatics tests, they cannot be used as a replacement for careful clinical evaluation. This may greatly enhance the analysis of gene variants by facilitating data sharing and straightforward exchange of selected variants associated with the phenotype. Thus, the difficulty in clinical bioinformatics is expected to restrain the market growth.

  • Cyber Security Concerns in Bioinformatics

Era software is known to contain vulnerabilities caused by imperfect code and misconfiguration. NGS-related software used to operate sequencing and laboratory equipment or carry out bioinformatics analyzes is no exception. Software vulnerabilities are exploited to gain unauthorized access to computer systems or networks, leak data, crash or otherwise disrupt various services.

However, the increasing computerization of DNA technology and biotechnology raises new bio-cyber security concerns. Vulnerabilities typically associated with traditional computer systems -- like the processing of untrusted input, side-channel leaks, poor authentication, falsified data, and vulnerabilities in cyber-physical systems -- now exist in biotechnology. The emerging bio-cyber security threats have threatened the DNA-Information Systems in bioinformatics.

For instance;

  • In 2020, The REvil or Sodinokibi ransomware group will take the credit for hacking and stealing 1 Terabyte (TB) of data from 10x Genomics which is for COVID-19 research
  • In 2018, Genomics England shifted genetic blueprint data for its 100,000 Genomes Project after being targeted by cyber-attacks from foreign parties. This allows the breach of data and can lead to misuse of individual genome

COVID-19 Impact on the Europe Bioinformatics Market

During the pandemic, the Europe bioinformatics sector is one that focuses on using a combination of biology and information technology. At the heart of the industry is biological data, which is analyzed and transformed using IT techniques. Bioinformatics has always had huge potential when it comes to providing essential support to many areas of scientific research. The tools that Bioinformatics can provide allow scientists to get to grips with larger data sets and to mine and analyze them to discover crucial information that could lead to key discoveries. Genetics and genomes have been the primary focus of Bioinformatics in recent years, including comparative genomics, DNA microarrays, and functional genomics.

Recent Development

  • In March 2022, Thermo Fisher Scientific Inc launched the CE-IVD Marked Next-Generation Sequencing (NGS) Instrument for Use in Clinical Labs. The CE-IVD Marked Next-Generation Sequencing Instrument is used to perform diagnostic testing and clinical research on a single instrument. The launch of the instrument resulted in the addition of a new product in the product range and the distribution of the NGS instrument, which is expected to increase the product revenue.

Europe Bioinformatics Market Scope

Europe bioinformatics market is segmented on the basis of six segments: type, sector, application, purchase mode, genomics, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Knowledge Management Tools
  • Bioinformatics Software
  • Services

On the basis of type, the Europe bioinformatics market is segmented into knowledge management tools, bioinformatics software, and services.

Sector

  • Medical biotechnology
  • Academics
  • Animal Biotechnology
  • Agricultural biotechnology
  • Environmental Biotechnology
  • Forensic biotechnology
  • Others

On the basis of sector, the Europe bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others.

Application

  • Genomics and Drug Development
  • Proteomics
  • Evolutionary Studies
  • Agricultural Studies
  • Veterinary Science
  • Metabolomics
  • Transcriptomics
  • Others

On the basis of application, the Europe bioinformatics market is segmented into genomics and drug development, proteomics, evolutionary studies, agricultural studies, veterinary science, metabolomics, transcriptomics, and others.

Purchase Mode

  • Group Purchase
  • Individual Purchase

On the basis of purchase mode, the Europe bioinformatics market is segmented into group purchases and individual purchases.

Method

  • Genomics
  • Proteomics

On the basis of method, the Europe bioinformatics market is segmented into genomics and proteomics.

End User

  • Research and Academic Institutes
  • Clinical Research Organization
  • Biotech and Pharmaceutical Companies
  • Research Laboratories
  • Hospital
  • Others

Get Exclusive Sample Copy of this Report Here

On the basis of end-user, the Europe bioinformatics market is segmented into research and academic institutes, clinical research organizations, biotech and pharmaceutical companies, research laboratories, hospitals, and others.

Europe Bioinformatics Market Regional Analysis/Insights

Europe bioinformatics market is analyzed, and market size insights and trends are provided by regions, type, sector, application, purchase mode, genomics, and end-user. as referenced above.

The countries covered in the Europe Bioinformatics market report are Germany, France, U.K., Italy,  Russia, Spain, Switzerland, Netherlands, Belgium, Turkey, Rest of Europe.

Germany is expected to dominate the market due to rise in awareness about bioinformatics sequencing and rise in count of collaborations between companies and bioinformatics research institutes in Germany are expected to drive the market growth.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of  brands and their challenges faced due to large or scarce competition from local and domestic brands impact sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Europe Bioinformatics Market Share Analysis

The Europe bioinformatics market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, the Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the Europe Bioinformatics market.

Some of the major players operating in the Europe Bioinformatics market are Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Waters Corporation, Dassault Systèmes, Bayer AG, PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam and GenoFAB, Inc.


SKU-

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE BIOINFORMATICS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHIC SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 RESEARCH METHODOLOGY

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 TYPE SEGMENT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 THE CATEGORY VS TIME GRID

2.13 SECONDARY SOURCES

2.14 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL

4.2 PORTER'S FIVE FORCES MODEL

5 REGULATIONS OF THE EUROPE BIOINFORMATICS MARKET

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 DECREASE IN THE COST OF GENETIC SEQUENCING PER BASE

6.1.2 GROWING NEED FOR BIOINFORMATICS

6.1.3 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS

6.1.4 USE OF BIOINFORMATICS IN PERSONALIZED MEDICINE

6.1.5 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS

6.2 RESTRAINTS

6.2.1 HIGH COST OF INSTRUMENTATION

6.2.2 DIFFICULTY IN CLINICAL BIOINFORMATICS ANALYSIS

6.2.3 CYBER SECURITY CONCERNS IN BIOINFORMATICS

6.3 OPPORTUNITIES

6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER

6.3.2 PRODUCT DEVELOPMENT IN RECENT YEARS

6.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY

6.4 CHALLENGES

6.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM BIOINFORMATICS TECHNOLOGY

6.4.2 CHALLENGES TO IMPLEMENTING BIOINFORMATICS TECHNOLOGY IN THE CLINICAL LABS

7 EUROPE BIOINFORMATICS MARKET, BY TYPE

7.1 OVERVIEW

7.2 SERVICES

7.2.1 DIAGNOSTICS CONSULTATION

7.2.2 DATA ANALYSIS

7.2.2.1 STRUCTURAL

7.2.2.2 FUNCTIONAL

7.3 BIOINFORMATICS SOFTWARE

7.3.1 INFORMATICS INFRASTRUCTURE AND PIPELINE SETUP

7.3.2 SAMPLE AND EXPERIMENT MANAGEMENT

7.3.3 SEQUENCING DATA ANALYSIS

7.3.3.1 SEQUENCE ANALYSIS PLATFORM

7.3.3.2 SEQUENCE ALIGNMENT PLATFORM

7.3.3.3 SEQUENCE MANIPULATION PLATFORM

7.3.3.4 STRUCTURAL ANALYSIS PLATFORM

7.3.3.5 OTHERS

7.3.4 BIOLOGICAL DATA INTERPRETATION

7.3.5 SPECIALIZED BIOINFORMATICS APPLICATIONS

7.3.5.1 SINGLE CELL GENE EXPRESSION

7.3.5.2 GENE EXPRESSION

7.3.5.3 VARIANT DETECTION

7.3.5.4 CNV ANALYSIS

7.3.5.5 METAGENOMICS

7.3.5.6 METHYLATION

7.3.5.7 CHIP-SEQ

7.3.5.8 NON-CODING RNA EXPRESSION

7.3.5.9 OTHERS

7.3.6 OTHERS

7.4 KNOWLEDGE MANAGEMENT TOOLS

7.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS

7.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS

8 EUROPE BIOINFORMATICS MARKET, BY SECTOR

8.1 OVERVIEW

8.2 MEDICAL BIOTECHNOLOGY

8.3 ACADEMICS

8.4 ANIMAL BIOTECHNOLOGY

8.5 AGRICULTURAL BIOTECHNOLOGY

8.6 ENVIRONMENTAL BIOTECHNOLOGY

8.7 FORENSIC BIOTECHNOLOGY

8.8 OTHERS

9 EUROPE BIOINFORMATICS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 GENOMICS & DRUG DEVELOPMENT

9.2.1 SERVICES

9.2.2 SEQUENCING PLATFORMS

9.2.3 KNOWLEDGE MANAGEMENT TOOLS

9.2.4 GENOMICS & DRUG DEVELOPMENT BY TYPE

9.2.4.1 PREVENTIVE MEDICINE

9.2.4.2 MOLECULAR MEDICINE

9.2.4.3 PERSONALIZED MEDICINE

9.2.4.4 CHEMOINFORMATICS AND DRUG DESIGN

9.2.4.5 ANTIBIOTIC RESISTANCE

9.3 PROTEOMICS

9.3.1 SERVICES

9.3.2 SERVICES SEQUENCING PLATFORMS

9.3.3 KNOWLEDGE MANAGEMENT TOOLS

9.4 AGRICULTURAL STUDIES

9.4.1 SERVICES

9.4.2 SERVICES SEQUENCING PLATFORMS

9.4.3 KNOWLEDGE MANAGEMENT TOOLS

9.5 TRANSCRIPTOMICS

9.5.1 SERVICES

9.5.2 SERVICES SEQUENCING PLATFORMS

9.5.3 KNOWLEDGE MANAGEMENT TOOLS

9.6 METABOLOMICS

9.6.1 SERVICES

9.6.2 SERVICES SEQUENCING PLATFORMS

9.6.3 KNOWLEDGE MANAGEMENT TOOLS

9.7 EVOLUTIONARY STUDIES

9.7.1 SERVICES

9.7.2 SERVICES SEQUENCING PLATFORMS

9.7.3 KNOWLEDGE MANAGEMENT TOOLS

9.8 VETERINARY SCIENCE

9.8.1 SERVICES

9.8.2 SERVICES SEQUENCING PLATFORMS

9.8.3 KNOWLEDGE MANAGEMENT TOOLS

9.9 OTHERS

9.9.1 SERVICES

9.9.2 SERVICES SEQUENCING PLATFORMS

9.9.3 KNOWLEDGE MANAGEMENT TOOLS

10 EUROPE BIOINFORMATICS MARKET, BY PURCHASE MODE

10.1 OVERVIEW

10.2 GROUP PURCHASE

10.3 INDIVIDUAL PURCHASE

11 EUROPE BIOINFORMATICS MARKET, BY METHOD

11.1 OVERVIEW

11.2 GENOMICS

11.2.1 DNA

11.2.2 RNA

11.3 PROTEOMICS

12 EUROPE BIOINFORMATICS MARKET, BY END USER

12.1 OVERVIEW

12.2 RESEARCH AND ACADEMIC INSTITUTES

12.3 CLINICAL RESEARCH ORGANIZATION

12.4 BIOTECH AND PHARMACEUTICAL COMPANIES

12.5 RESEARCH LABORATORIES

12.6 HOSPITALS

12.7 OTHERS

13 EUROPE BIOINFORMATICS MARKET, BY REGION

13.1 EUROPE

13.1.1 GERMANY

13.1.2 FRANCE

13.1.3 U.K.

13.1.4 ITALY

13.1.5 RUSSIA

13.1.6 SPAIN

13.1.7 SWITZERLAND

13.1.8 NETHERLANDS

13.1.9 BELGIUM

13.1.10 TURKEY

13.1.11 REST OF EUROPE

14 EUROPE BIOINFORMATICS MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: EUROPE

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 BAYER AG

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 THERMO FISHER SCIENTIFIC INC

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 EUROFINS SCIENTIFIC

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 DASSAULT SYSTÈMES

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 AGILENT TECHNOLOGIES, INC

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENTS

16.6 ASTRIDBIO TECHNOLOGIES INC.

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENTS

16.7 BGI (A SUBSIDIARY OF BGI GROUP)

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 BIOBAM

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENTS

16.9 DNANEXUS INC.

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENTS

16.1 DNASTAR

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 GENOFAB, INC

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 ILLUMINA, INC

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENTS

16.13 PARTEK INCORPORATED

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENTS

16.14 PERKINELMER INC.

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENTS

16.15 QIAGEN

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 QUEST DIAGNOSTICS INCORPORATED (2021)

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 PRODUCT PORTFOLIO

16.16.4 RECENT DEVELOPMENTS

16.17 SEVEN BRIDGES GENOMICS

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 SOPHIA GENETICS

16.18.1 COMPANY SNAPSHOT

16.18.2 REVENUE ANALYSIS

16.18.3 PRODUCT PORTFOLIO

16.18.4 RECENT DEVELOPMENTS

16.19 STRAND LIFE SCIENCES

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 WATERS CORPORATION

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

TABLE 1 BIOINFORMATICSCOST PER SAMPLE

TABLE 2 EUROPE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 3 EUROPE SERVICES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 EUROPE SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 5 EUROPE DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 6 EUROPE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 EUROPE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 8 EUROPE SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 9 EUROPE SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 10 EUROPE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 EUROPE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 13 EUROPE MEDICAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 EUROPE ACADEMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 EUROPE ANIMAL TECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 EUROPE AGRICULTURAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 EUROPE ENVIRONMENTAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 EUROPE FORENSIC BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 21 EUROPE GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 EUROPE GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 23 EUROPE GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 24 EUROPE PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 EUROPE PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 26 EUROPE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 EUROPE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 28 EUROPE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 EUROPE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 30 EUROPE METABOLOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 EUROPE METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 32 EUROPE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 EUROPE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 34 EUROPE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 EUROPE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 36 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 38 EUROPE BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 39 EUROPE GROUP PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 EUROPE INDIVIDUAL PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 EUROPE BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 42 EUROPE GENOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 EUROPE GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 44 EUROPE PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 EUROPE BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 46 EUROPE RESEARCH AND ACADEMIC INSTITUTES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 47 EUROPE CLINICAL RESEARCH ORGANIZATION IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 48 EUROPE BIOTECH AND PHARMACEUTICAL COMPANIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 49 EUROPE RESEARCH LABORATORIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 EUROPE HOSPITALS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 52 EUROPE BIOINFORMATICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 53 EUROPE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 EUROPE SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 55 EUROPE DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 EUROPE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 57 EUROPE SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 58 EUROPE SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 59 EUROPE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 60 EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 61 EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 62 EUROPE GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 63 EUROPE GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 64 EUROPE PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 65 EUROPE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 66 EUROPE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 67 EUROPE METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 68 EUROPE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 69 EUROPE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 70 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 71 EUROPE BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 72 EUROPE BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 73 EUROPE GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 74 EUROPE BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 75 GERMANY BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 76 GERMANY SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 77 GERMANY DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 78 GERMANY BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 79 GERMANY SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 80 GERMANY SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 81 GERMANY KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 82 GERMANY BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 83 GERMANY BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 84 GERMANY GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 85 GERMANY GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 86 GERMANY PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 87 GERMANY AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 88 GERMANY TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 89 GERMANY METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 90 GERMANY EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 91 GERMANY VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 92 GERMANY OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 93 GERMANY BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 94 GERMANY BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 95 GERMANY GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 96 GERMANY BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 97 FRANCE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 FRANCE SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 99 FRANCE DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 100 FRANCE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 101 FRANCE SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 FRANCE SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 FRANCE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 FRANCE BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 105 FRANCE BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 106 FRANCE GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 107 FRANCE GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 108 FRANCE PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 109 FRANCE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 110 FRANCE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 111 FRANCE METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 112 FRANCE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 113 FRANCE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 114 FRANCE OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 115 FRANCE BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 116 FRANCE BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 117 FRANCE GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 118 FRANCE BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 119 U.K. BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 120 U.K. SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 121 U.K. DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 122 U.K. BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 123 U.K. SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 U.K. SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 125 U.K. KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 126 U.K. BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 127 U.K. BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 128 U.K. GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 129 U.K. GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 130 U.K. PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 131 U.K. AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 132 U.K. TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 133 U.K. METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 134 U.K. EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 135 U.K. VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 136 U.K. OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 137 U.K. BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 138 U.K. BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 139 U.K GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 140 U.K. BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 141 ITALY BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 142 ITALY SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 143 ITALY DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 144 ITALY BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 145 ITALY SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 146 ITALY SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 147 ITALY KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 148 ITALY BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 149 ITALY BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 150 ITALY GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 151 ITALY GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 152 ITALY PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 153 ITALY AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 154 ITALY TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 155 ITALY METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 156 ITALY EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 157 ITALY VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 158 ITALY OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 159 ITALY BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 160 ITALY BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 161 ITALY GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 162 ITALY BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 163 RUSSIA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 164 RUSSIA SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 165 RUSSIA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 166 RUSSIA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 167 RUSSIA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 168 RUSSIA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 169 RUSSIA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 170 RUSSIA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 171 RUSSIA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 172 RUSSIA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 173 RUSSIA GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 174 RUSSIA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 175 RUSSIA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 176 RUSSIA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 177 RUSSIA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 178 RUSSIA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 179 RUSSIA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 180 RUSSIA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 181 RUSSIA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 182 RUSSIA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 183 RUSSIA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 184 RUSSIA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 185 SPAIN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 186 SPAIN SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 187 SPAIN DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 188 SPAIN BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 189 SPAIN SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 190 SPAIN SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 191 SPAIN KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 192 SPAIN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 193 SPAIN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 194 SPAIN GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 195 SPAIN GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 196 SPAIN PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 197 SPAIN AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 198 SPAIN TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 199 SPAIN METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 200 SPAIN EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 201 SPAIN VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 202 SPAIN OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 203 SPAIN BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 204 SPAIN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 205 SPAIN GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 206 SPAIN BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 207 SWITZERLAND BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 208 SWITZERLAND SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 209 SWITZERLAND DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 210 SWITZERLAND BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 211 SWITZERLAND SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 212 SWITZERLAND SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 213 SWITZERLAND KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 214 SWITZERLAND BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 215 SWITZERLAND BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 216 SWITZERLAND GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 217 SWITZERLAND GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 218 SWITZERLAND PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 219 SWITZERLAND AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 220 SWITZERLAND TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 221 SWITZERLAND METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 222 SWITZERLAND EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 223 SWITZERLAND VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 224 SWITZERLAND OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 225 SWITZERLAND BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 226 SWITZERLAND BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 227 SWITZERLAND GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 228 SWITZERLAND BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 229 NETHERLANDS BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 230 NETHERLANDS SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 231 NETHERLANDS DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 232 NETHERLANDS BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 233 NETHERLANDS SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 234 NETHERLANDS SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 235 NETHERLANDS KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 236 NETHERLANDS BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 237 NETHERLANDS BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 238 NETHERLANDS GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 239 NETHERLANDS GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 240 NETHERLANDS PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 241 NETHERLANDS AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 242 NETHERLANDS TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 243 NETHERLANDS METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 244 NETHERLANDS EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 245 NETHERLANDS VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 246 NETHERLANDS OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 247 NETHERLANDS BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 248 NETHERLANDS BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 249 NETHERLANDS GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 250 NETHERLANDS BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 251 BELGIUM BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 252 BELGIUM SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 253 BELGIUM DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 254 BELGIUM BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 255 BELGIUM SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 256 BELGIUM SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 257 BELGIUM KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 258 BELGIUM BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 259 BELGIUM BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 260 BELGIUM GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 261 BELGIUM GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 262 BELGIUM PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 263 BELGIUM AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 264 BELGIUM TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 265 BELGIUM METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 266 BELGIUM EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 267 BELGIUM VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 268 BELGIUM OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 269 BELGIUM BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 270 BELGIUM BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 271 BELGIUM GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 272 BELGIUM BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 273 TURKEY BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 274 TURKEY SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 275 TURKEY DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 276 TURKEY BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 277 TURKEY SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 278 TURKEY SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 279 TURKEY KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 280 TURKEY BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 281 TURKEY BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 282 TURKEY GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 283 TURKEY GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 284 TURKEY PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 285 TURKEY AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 286 TURKEY TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 287 TURKEY METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 288 TURKEY EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 289 TURKEY VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 290 TURKEY OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 291 TURKEY BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 292 TURKEY BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 293 TURKEY GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 294 TURKEY BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 295 REST OF EUROPE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

List of Figure

FIGURE 1 EUROPE BIOINFORMATICS MARKET: SEGMENTATION

FIGURE 2 EUROPE BIOINFORMATICS MARKET: GEOGRAPHIC SCOPE

FIGURE 3 EUROPE BIOINFORMATICS MARKET: DATA TRIANGULATION

FIGURE 4 EUROPE BIOINFORMATICS MARKET: SNAPSHOT

FIGURE 5 EUROPE BIOINFORMATICS MARKET: BOTTOM-UP APPROACH

FIGURE 6 EUROPE BIOINFORMATICS MARKET: TOP-DOWN APPROACH

FIGURE 7 EUROPE BIOINFORMATICS MARKET: INTERVIEWS BY REGION AND DESIGNATION

FIGURE 8 EUROPE BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE BIOINFORMATICS MARKET: APPLICATION COVERAGE GRID

FIGURE 11 EUROPE BIOINFORMATICS MARKET: THE CATEGORY VS TIME GRID

FIGURE 12 EUROPE BIOINFORMATICS MARKET SEGMENTATION

FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE EUROPE DENTAL LABMARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 GROWING APPLICATIONS OF BIOINFORMATICS AND LOW COST OF BIOINFORMATICS SEQUENCING ARE EXPECTED TO DRIVE THE MARKET FOR EUROPE BIOINFORMATICS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 15 SERVICES SEGMENT ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE BIOINFORMATICS MARKET IN 2019 & 2026

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE BIOINFORMATICS MARKET

FIGURE 17 DECREASE IN COST OF PER BASE SEQUENCING

FIGURE 18 GROWING NEED FOR BIOINFORMATICS IN VITAL APPLICATIONS

FIGURE 19 EUROPE BIOINFORMATICS MARKET: BY TYPE, 2021

FIGURE 20 EUROPE BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 21 EUROPE BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 22 EUROPE BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 23 EUROPE BIOINFORMATICS MARKET: BY SECTOR, 2021

FIGURE 24 EUROPE BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)

FIGURE 25 EUROPE BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)

FIGURE 26 EUROPE BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE

FIGURE 27 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, 2021

FIGURE 28 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 29 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 30 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 31 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, 2021

FIGURE 32 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, 2022-2029 (USD MILLION)

FIGURE 33 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, CAGR (2022-2029)

FIGURE 34 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, LIFELINE CURVE

FIGURE 35 EUROPE BIOINFORMATICS MARKET: BY METHOD, 2021

FIGURE 36 EUROPE BIOINFORMATICS MARKET: BY METHOD, 2022-2029 (USD MILLION)

FIGURE 37 EUROPE BIOINFORMATICS MARKET: BY METHOD, CAGR (2022-2029)

FIGURE 38 EUROPE BIOINFORMATICS MARKET: BY METHOD, LIFELINE CURVE

FIGURE 39 EUROPE BIOINFORMATICS MARKET: BY END USER, 2021

FIGURE 40 EUROPE BIOINFORMATICS MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 41 EUROPE BIOINFORMATICS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 42 EUROPE BIOINFORMATICS MARKET: BY END USER, LIFELINE CURVE

FIGURE 43 EUROPE BIOINFORMATICS MARKET: SNAPSHOT (2021)

FIGURE 44 EUROPE BIOINFORMATICS MARKET: BY COUNTRY (2021)

FIGURE 45 EUROPE BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 46 EUROPE BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 47 EUROPE BIOINFORMATICS MARKET: BY TYPE (2022-2029)

FIGURE 48 EUROPE BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)

View Infographics

FIGURE 1 EUROPE BIOINFORMATICS MARKET: SEGMENTATION

FIGURE 2 EUROPE BIOINFORMATICS MARKET: GEOGRAPHIC SCOPE

FIGURE 3 EUROPE BIOINFORMATICS MARKET: DATA TRIANGULATION

FIGURE 4 EUROPE BIOINFORMATICS MARKET: SNAPSHOT

FIGURE 5 EUROPE BIOINFORMATICS MARKET: BOTTOM-UP APPROACH

FIGURE 6 EUROPE BIOINFORMATICS MARKET: TOP-DOWN APPROACH

FIGURE 7 EUROPE BIOINFORMATICS MARKET: INTERVIEWS BY REGION AND DESIGNATION

FIGURE 8 EUROPE BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE BIOINFORMATICS MARKET: APPLICATION COVERAGE GRID

FIGURE 11 EUROPE BIOINFORMATICS MARKET: THE CATEGORY VS TIME GRID

FIGURE 12 EUROPE BIOINFORMATICS MARKET SEGMENTATION

FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE EUROPE DENTAL LABMARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 GROWING APPLICATIONS OF BIOINFORMATICS AND LOW COST OF BIOINFORMATICS SEQUENCING ARE EXPECTED TO DRIVE THE MARKET FOR EUROPE BIOINFORMATICS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 15 SERVICES SEGMENT ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE BIOINFORMATICS MARKET IN 2019 & 2026

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE BIOINFORMATICS MARKET

FIGURE 17 DECREASE IN COST OF PER BASE SEQUENCING

FIGURE 18 GROWING NEED FOR BIOINFORMATICS IN VITAL APPLICATIONS

FIGURE 19 EUROPE BIOINFORMATICS MARKET: BY TYPE, 2021

FIGURE 20 EUROPE BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 21 EUROPE BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 22 EUROPE BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 23 EUROPE BIOINFORMATICS MARKET: BY SECTOR, 2021

FIGURE 24 EUROPE BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)

FIGURE 25 EUROPE BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)

FIGURE 26 EUROPE BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE

FIGURE 27 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, 2021

FIGURE 28 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 29 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 30 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 31 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, 2021

FIGURE 32 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, 2022-2029 (USD MILLION)

FIGURE 33 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, CAGR (2022-2029)

FIGURE 34 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, LIFELINE CURVE

FIGURE 35 EUROPE BIOINFORMATICS MARKET: BY METHOD, 2021

FIGURE 36 EUROPE BIOINFORMATICS MARKET: BY METHOD, 2022-2029 (USD MILLION)

FIGURE 37 EUROPE BIOINFORMATICS MARKET: BY METHOD, CAGR (2022-2029)

FIGURE 38 EUROPE BIOINFORMATICS MARKET: BY METHOD, LIFELINE CURVE

FIGURE 39 EUROPE BIOINFORMATICS MARKET: BY END USER, 2021

FIGURE 40 EUROPE BIOINFORMATICS MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 41 EUROPE BIOINFORMATICS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 42 EUROPE BIOINFORMATICS MARKET: BY END USER, LIFELINE CURVE

FIGURE 43 EUROPE BIOINFORMATICS MARKET: SNAPSHOT (2021)

FIGURE 44 EUROPE BIOINFORMATICS MARKET: BY COUNTRY (2021)

FIGURE 45 EUROPE BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 46 EUROPE BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 47 EUROPE BIOINFORMATICS MARKET: BY TYPE (2022-2029)

FIGURE 48 EUROPE BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 8500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19